Skip to main content
. 2012 Feb;50(2):232–237. doi: 10.1128/JCM.05253-11

Table 3.

Detection of CMV gB and gH genotypes in DBS from children with hearing impairment at the age of 3 to 5 years (22)b

DBS from newborn gB genotype gH genotype CMV IE load in DBS (log10 copies/ml whole blood) Symptom(s) at birth Developmental scorea Severity of hearing loss
1 3 2 4.1 None 59 60–90 dB
2 ND ND 3.3 None 84 40–60 dB
3 4 1 4.9 None 72 >90 dB (CI)
4 2 2 3.6 None 68 60–90 dB
5 3 2 5.9 IUGR, microcephaly, seizures 30 >90 dB (CI)
6 2 1 5.3 IUGR, petechiae, hepatosplenomegaly, jaundice, thrombocytopenia 50 >90 dB (CI)
7 4 1 5.3 IUGR, jaundice, microcephaly Unknown >90 dB
8 2 1 <3.0 None 82 >90 dB (CI)
9 ND ND 3.6 Cataract 56 >90 dB (CI)
a

The general development score is a summary score that provides an overall index of development by including 10 of the most age-discriminating items from each scale of the Child Development Inventory. The Child Development Inventory is a standardized instrument (parent questionnaire) designed to assess the social development, language development, and motor development of young children. Higher scores indicate better development.

b

Abbreviations: IE, immediate-early antigen; DBS, dried blood spots; gB, glycoprotein B; gH, glycoprotein H; CI, cochlear implant; IUGR, intrauterine growth retardation; ND, not detected.